These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 20801094

  • 21. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
    Duerr HP, Raddatz G, Eichner M.
    Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
    [Abstract] [Full Text] [Related]

  • 22. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH.
    Parasit Vectors; 2012 Feb 07; 5():28. PubMed ID: 22313631
    [Abstract] [Full Text] [Related]

  • 23. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN, Eyamba A, Nwane P, Enyong P, Yaya S, Baldiagaï J, Madi TK, Yougouda A, Andze GO, Richards FO.
    Am J Trop Med Hyg; 2011 Dec 07; 85(6):1041-9. PubMed ID: 22144441
    [Abstract] [Full Text] [Related]

  • 24. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
    Eisenbarth A, Achukwi MD, Renz A.
    PLoS Negl Trop Dis; 2016 Feb 07; 10(2):e0004392. PubMed ID: 26926855
    [Abstract] [Full Text] [Related]

  • 25. The Mectizan Donation Program (MDP).
    Thylefors B.
    Ann Trop Med Parasitol; 2008 Sep 07; 102 Suppl 1():39-44. PubMed ID: 18718154
    [Abstract] [Full Text] [Related]

  • 26. Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution.
    Ayisi F, de Souza DK, Tallant J, Biholong BD, Fokam EB, Boakye DA.
    Parasit Vectors; 2024 May 13; 17(1):219. PubMed ID: 38741212
    [Abstract] [Full Text] [Related]

  • 27. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
    Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, Kamgno J, Robert A.
    Parasit Vectors; 2017 Aug 03; 10(1):373. PubMed ID: 28774318
    [Abstract] [Full Text] [Related]

  • 28. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
    Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW.
    Lancet; 2001 May 05; 357(9266):1415-6. PubMed ID: 11356444
    [Abstract] [Full Text] [Related]

  • 29. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M, Chippaux JP, Ernould JC, Quillevere D, Prod'hon J.
    Am J Trop Med Hyg; 1995 Jul 05; 53(1):63-7. PubMed ID: 7625535
    [Abstract] [Full Text] [Related]

  • 30. The Onchocerciasis Control Programme in West Africa (OCP).
    Boatin B.
    Ann Trop Med Parasitol; 2008 Sep 05; 102 Suppl 1():13-7. PubMed ID: 18718148
    [Abstract] [Full Text] [Related]

  • 31. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R, Tukesiga E, Büttner DW, Garms R.
    Trop Med Int Health; 2004 Aug 05; 9(8):882-6. PubMed ID: 15303993
    [Abstract] [Full Text] [Related]

  • 32. Interruption of Onchocerca volvulus transmission in Northern Venezuela.
    Convit J, Schuler H, Borges R, Olivero V, Domínguez-Vázquez A, Frontado H, Grillet ME.
    Parasit Vectors; 2013 Oct 07; 6(1):289. PubMed ID: 24499653
    [Abstract] [Full Text] [Related]

  • 33. Onchocercal eye disease and the impact of Mectizan treatment.
    Abiose A.
    Ann Trop Med Parasitol; 1998 Apr 07; 92 Suppl 1():S11-22. PubMed ID: 9861263
    [Abstract] [Full Text] [Related]

  • 34. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.
    Eng JK, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, Beech RN, Unnasch TR, Awadzi K, Lubega GW, Prichard RK.
    Mol Biochem Parasitol; 2006 Dec 07; 150(2):229-35. PubMed ID: 17007942
    [Abstract] [Full Text] [Related]

  • 35. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
    Richards FO, Nwoke BEB, Zarroug I, Tukahebwa E, Negussu N, Higazi TB, Oguttu D, Tadesse Z, Miri E, Aziz N, Habomugisha P, Katabarwa M.
    Infect Dis Poverty; 2019 Jul 15; 8(1):52. PubMed ID: 31303175
    [Abstract] [Full Text] [Related]

  • 36. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
    Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, Ahmed K, Boatin BA, Boakye DA, Edwards G.
    Ann Trop Med Parasitol; 2004 Jun 15; 98(4):359-70. PubMed ID: 15228717
    [Abstract] [Full Text] [Related]

  • 37. The impact of Mectizan on the transmission of onchocerciasis.
    Boatin BA, Hougard JM, Alley ES, Akpoboua LK, Yaméogo L, Dembélé N, Sékétéli A, Dadzie KY.
    Ann Trop Med Parasitol; 1998 Apr 15; 92 Suppl 1():S46-60. PubMed ID: 9861267
    [Abstract] [Full Text] [Related]

  • 38. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
    Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, Lazdins-Helds JK, Ardrey AE, Addy ET, Quartey BT, Ahmed K, Boatin BA, Soumbey-Alley EW.
    Ann Trop Med Parasitol; 2004 Apr 15; 98(3):231-49. PubMed ID: 15119969
    [Abstract] [Full Text] [Related]

  • 39. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K, Dadzie KY, Shulz-Key H, Haddock DR, Gilles HM, Aziz MA.
    Ann Trop Med Parasitol; 1985 Feb 15; 79(1):63-78. PubMed ID: 3838638
    [Abstract] [Full Text] [Related]

  • 40. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
    Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke NJ, Plaisier AP, Remme JH, Lazdins J, Borsboom GJ, Habbema JD.
    BMC Public Health; 2001 Feb 15; 1():12. PubMed ID: 11734070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.